Vi­gene Bio­sciences goes big on Mary­land vi­ral vec­tor ex­pan­sion as it rides high on Al­tim­mune vac­cine deal

Boost­ed by a gang­busters year for Rockville-based Emer­gent BioSo­lu­tions and its vi­ral vec­tors for Covid-19 vac­cines, the state of Mary­land has con­tin­ued to ce­ment its place as a hotbed for next-gen man­u­fac­tur­ing. Now, a small­er play­er is look­ing to build out its own small foothold in the state.

Vi­gene Bio­sciences, al­so based in Rockville, has snagged a pub­lic-pri­vate part­ner­ship with the state of Mary­land and its home base of Mont­gomery Coun­ty to add 52,000 feet of man­u­fac­tur­ing space at its head­quar­ters site.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.